PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"33882225","Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group.","N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.","Sadoff J","N Engl J Med","2021","2021/04/21","PMC8220996","","10.1056/NEJMoa2101544"
"35139271","Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S","Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group.","N Engl J Med. 2022 Mar 3;386(9):847-860. doi: 10.1056/NEJMoa2117608. Epub 2022 Feb 9.","Sadoff J","N Engl J Med","2022","2022/02/09","PMC8849184","","10.1056/NEJMoa2117608"
"33761206","Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L; HVTN 702 Study Team.","N Engl J Med. 2021 Mar 25;384(12):1089-1100. doi: 10.1056/NEJMoa2031499.","Gray GE","N Engl J Med","2021","2021/03/24","PMC7888373","","10.1056/NEJMoa2031499"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"35758878","Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ.","J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260.","Moodie Z","J Infect Dis","2022","2022/06/27","PMC9890908","","10.1093/infdis/jiac260"
"34002949","The path to find an HIV vaccine","Gray GE, Corey L.","J Int AIDS Soc. 2021 May;24(5):e25749. doi: 10.1002/jia2.25749.","Gray GE","J Int AIDS Soc","2021","2021/05/18","PMC8130233","","10.1002/jia2.25749"
"26985884","Approaches to preventative and therapeutic HIV vaccines","Gray GE, Laher F, Lazarus E, Ensoli B, Corey L.","Curr Opin Virol. 2016 Apr;17:104-109. doi: 10.1016/j.coviro.2016.02.010. Epub 2016 Mar 15.","Gray GE","Curr Opin Virol","2016","2016/03/18","PMC5020417","NIHMS766247","10.1016/j.coviro.2016.02.010"
"25170103","Reevaluating HIV vaccine clinical trials policy for infants","Gray GE, Corey L.","J Infect Dis. 2015 Feb 15;211(4):501-3. doi: 10.1093/infdis/jiu445. Epub 2014 Aug 27.","Gray GE","J Infect Dis","2015","2014/08/30","","","10.1093/infdis/jiu445"
"30047376","Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, Michael NL, Peter L, Nkolola JP, Borducchi EN, Chandrashekar A, Jetton D, Stephenson KE, Li W, Korber B, Tomaras GD, Montefiori DC, Gray G, Frahm N, McElrath MJ, Baden L, Johnson J, Hutter J, Swann E, Karita E, Kibuuka H, Mpendo J, Garrett N, Mngadi K, Chinyenze K, Priddy F, Lazarus E, Laher F, Nitayapan S, Pitisuttithum P, Bart S, Campbell T, Feldman R, Lucksinger G, Borremans C, Callewaert K, Roten R, Sadoff J, Scheppler L, Weijtens M, Feddes-de Boer K, van Manen D, Vreugdenhil J, Zahn R, Lavreys L, Nijs S, Tolboom J, Hendriks J, Euler Z, Pau MG, Schuitemaker H.","Lancet. 2018 Jul 21;392(10143):232-243. doi: 10.1016/S0140-6736(18)31364-3. Epub 2018 Jul 6.","Barouch DH","Lancet","2018","2018/07/27","PMC6192527","NIHMS990078","10.1016/S0140-6736(18)31364-3"
"31099956","The aspirational necessity of HIV prevention","Corey L, Gray GE, Buchbinder SP.","J Int AIDS Soc. 2019 May;22(5):e25289. doi: 10.1002/jia2.25289.","Corey L","J Int AIDS Soc","2019","2019/05/18","PMC6524609","","10.1002/jia2.25289"
"31806257","The complex challenges of HIV vaccine development require renewed and expanded global commitment","Bekker LG, Tatoud R, Dabis F, Feinberg M, Kaleebu P, Marovich M, Ndung'u T, Russell N, Johnson J, Luba M, Fauci AS, Morris L, Pantaleo G, Buchbinder S, Gray G, Vekemans J, Kim JH, Levy Y, Corey L, Shattock R, Makanga M, Williamson C, Dieffenbach C, Goodenow MM, Shao Y, Staprans S, Warren M, Johnston MI.","Lancet. 2020 Feb 1;395(10221):384-388. doi: 10.1016/S0140-6736(19)32682-0. Epub 2019 Dec 2.","Bekker LG","Lancet","2020","2019/12/07","","","10.1016/S0140-6736(19)32682-0"
"26933962","Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?","Gray GE, Laher F, Doherty T, Abdool Karim S, Hammer S, Mascola J, Beyrer C, Corey L.","PLoS Biol. 2016 Mar 2;14(3):e1002372. doi: 10.1371/journal.pbio.1002372. eCollection 2016 Mar.","Gray GE","PLoS Biol","2016","2016/03/03","PMC4774984","","10.1371/journal.pbio.1002372"
"36240834","Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel","Miner MD, Hatherill M, Mave V, Gray GE, Nachman S, Read SW, White RG, Hesseling A, Cobelens F, Patel S, Frick M, Bailey T, Seder R, Flynn J, Rengarajan J, Kaushal D, Hanekom W, Schmidt AC, Scriba TJ, Nemes E, Andersen-Nissen E, Landay A, Dorman SE, Aldrovandi G, Cranmer LM, Day CL, Garcia-Basteiro AL, Fiore-Gartland A, Mogg R, Kublin JG, Gupta A, Churchyard G.","Lancet HIV. 2022 Nov;9(11):e791-e800. doi: 10.1016/S2352-3018(22)00255-7. Epub 2022 Oct 11.","Miner MD","Lancet HIV","2022","2022/10/14","PMC9667733","NIHMS1843749","10.1016/S2352-3018(22)00255-7"
"26827165","Selection of HIV vaccine candidates for concurrent testing in an efficacy trial","Huang Y, DiazGranados C, Janes H, Huang Y, deCamp AC, Metch B, Grant S, Sanchez B, Phogat S, Koutsoukos M, Kanesa-Thasan N, Bourguignon P, Collard A, Buchbinder S, Tomaras GD, McElrath J, Gray G, Kublin JG, Corey L, Gilbert PB.","Curr Opin Virol. 2016 Apr;17:57-65. doi: 10.1016/j.coviro.2016.01.007. Epub 2016 Jan 29.","Huang Y","Curr Opin Virol","2016","2016/02/01","PMC4902743","NIHMS756136","10.1016/j.coviro.2016.01.007"
"29732896","Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa","Janes H, Corey L, Ramjee G, Carpp LN, Lombard C, Cohen MS, Gilbert PB, Gray GE.","AIDS Res Hum Retroviruses. 2018 Aug;34(8):645-656. doi: 10.1089/AID.2018.0031. Epub 2018 Jun 19.","Janes H","AIDS Res Hum Retroviruses","2018","2018/05/08","PMC6080090","","10.1089/AID.2018.0031"
"35353885","High Asymptomatic Carriage With the Omicron Variant in South Africa","Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, Espy N, Wallis CL, Randhawa AK, Miner MD, Ketter N, Yacovone M, Goga A, Huang Y, Hural J, Kotze P, Bekker LG, Gray GE, Corey L; Ubuntu Study Team.","Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.","Garrett N","Clin Infect Dis","2022","2022/03/30","PMC9383623","","10.1093/cid/ciac237"
"35809579","Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa","Goga A, Bekker LG, Garrett N, Reddy T, Yende-Zuma N, Fairall L, Moultrie H, Takalani A, Trivella V, Faesen M, Bailey V, Seocharan I, Gray GE; Sisonke study team.","Lancet. 2022 Jul 23;400(10348):269-271. doi: 10.1016/S0140-6736(22)01190-4. Epub 2022 Jul 6.","Goga A","Lancet","2022","2022/07/09","PMC9259009","","10.1016/S0140-6736(22)01190-4"
"34077639","Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study","Takuva S, Takalani A, Garrett N, Goga A, Peter J, Louw V, Opie J, Jacobson B, Sanne I, Gail-Bekker L, Gray G.","N Engl J Med. 2021 Aug 5;385(6):570-571. doi: 10.1056/NEJMc2107920. Epub 2021 Jun 2.","Takuva S","N Engl J Med","2021","2021/06/02","PMC8190951","","10.1056/NEJMc2107920"
"26578538","Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples","Magaret AS, Mujugira A, Hughes JP, Lingappa J, Bukusi EA, DeBruyn G, Delany-Moretlwe S, Fife KH, Gray GE, Kapiga S, Karita E, Mugo NR, Rees H, Ronald A, Vwalika B, Were E, Celum C, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.","Clin Infect Dis. 2016 Feb 15;62(4):456-61. doi: 10.1093/cid/civ908. Epub 2015 Nov 17.","Magaret AS","Clin Infect Dis","2016","2015/11/19","PMC4725379","","10.1093/cid/civ908"
"33859204","Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans","Seaton KE, Deal A, Han X, Li SS, Clayton A, Heptinstall J, Duerr A, Allen MA, Shen X, Sawant S, Yates NL, Spearman P, Churchyard G, Goepfert PA, Maenza J, Gray G, Pantaleo G, Polakowski L, Robinson HL, Grant S, Randhawa AK, Huang Y, Morgan C, Grunenberg N, Karuna S, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD; NIAID HIV Vaccine Trials Network (HVTN) 076, 088, 086, 096, 097, 205 Study Teams.","NPJ Vaccines. 2021 Apr 15;6(1):56. doi: 10.1038/s41541-021-00305-8.","Seaton KE","NPJ Vaccines","2021","2021/04/16","PMC8050318","","10.1038/s41541-021-00305-8"
"36357712","Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial","Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Le Gars M, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, Paiva de Sousa L, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Immune Assays Team; the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; and the United States Government (USG)/CoVPN Biostatistics Team.","Nat Microbiol. 2022 Dec;7(12):1996-2010. doi: 10.1038/s41564-022-01262-1. Epub 2022 Nov 10.","Fong Y","Nat Microbiol","2022","2022/11/10","PMC10166187","NIHMS1867012","10.1038/s41564-022-01262-1"
"37020953","Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection","Mackelprang RD, Filali-Mouhim A, Richardson B, Lefebvre F, Katabira E, Ronald A, Gray G, Cohen KW, Klatt NR, Pecor T, Celum C, McElrath MJ, Hughes SM, Hladik F, Cameron MJ, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study; Partners PrEP Study Teams.","iScience. 2023 Mar 21;26(4):106454. doi: 10.1016/j.isci.2023.106454. eCollection 2023 Apr 21.","Mackelprang RD","iScience","2023","2023/04/06","PMC10067744","","10.1016/j.isci.2023.106454"
"35441174","Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial","Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Gars ML, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, de Sousa LP, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Janssen Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team.","medRxiv. 2022 Apr 12:2022.04.06.22272763. doi: 10.1101/2022.04.06.22272763. Preprint.","Fong Y","medRxiv","2022","2022/04/20","PMC9016647","","10.1101/2022.04.06.22272763"
"34195685","CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions","Richert-Spuhler LE, Mar CM, Shinde P, Wu F, Hong T, Greene E, Hou S, Thomas K, Gottardo R, Mugo N, de Bruyn G, Celum C, Baeten JM, Lingappa JR, Lund JM; Partners in Prevention HSV/HIV Transmission Study; and the Partners PrEP Study Teams.","Cell Rep Med. 2021 Jun 15;2(6):100322. doi: 10.1016/j.xcrm.2021.100322. eCollection 2021 Jun 15.","Richert-Spuhler LE","Cell Rep Med","2021","2021/07/01","PMC8233694","","10.1016/j.xcrm.2021.100322"
"37385888","Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials","Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A; COVID-19 Prevention Network CoVPN.","Vaccine. 2023 Jul 25;41(33):4899-4906. doi: 10.1016/j.vaccine.2023.06.066. Epub 2023 Jun 23.","Turley CB","Vaccine","2023","2023/06/29","PMC10288314","","10.1016/j.vaccine.2023.06.066"
"36689221","Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials","Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG; COVID-19 Prevention Network.","JAMA Netw Open. 2023 Jan 3;6(1):e2251974. doi: 10.1001/jamanetworkopen.2022.51974.","Mena Lora AJ","JAMA Netw Open","2023","2023/01/23","","","10.1001/jamanetworkopen.2022.51974"
"33720973","Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk","Andersen-Nissen E, Fiore-Gartland A, Ballweber Fleming L, Carpp LN, Naidoo AF, Harper MS, Voillet V, Grunenberg N, Laher F, Innes C, Bekker LG, Kublin JG, Huang Y, Ferrari G, Tomaras GD, Gray G, Gilbert PB, McElrath MJ.","PLoS Pathog. 2021 Mar 15;17(3):e1009363. doi: 10.1371/journal.ppat.1009363. eCollection 2021 Mar.","Andersen-Nissen E","PLoS Pathog","2021","2021/03/15","PMC7959397","","10.1371/journal.ppat.1009363"
"31534016","Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa","Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L.","Sci Transl Med. 2019 Sep 18;11(510):eaax1880. doi: 10.1126/scitranslmed.aax1880.","Gray GE","Sci Transl Med","2019","2019/09/20","PMC7199879","NIHMS1054745","10.1126/scitranslmed.aax1880"
"36929319","Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa","Malahleha M, Laher F, Dilraj A, Smith P, Gray GE, Grove D, Odhiambo JA, Andrasik MP, Grunenberg NA, Moodie Z, Huang Y, Borate BR, Gillespie KM, Allen M, Atujuna M, Singh N, Kalonji D, Meintjes G, Kotze P, Bekker LG, Janes H.","AIDS Behav. 2023 Sep;27(9):3027-3037. doi: 10.1007/s10461-023-04025-z. Epub 2023 Mar 16.","Malahleha M","AIDS Behav","2023","2023/03/17","PMC10386918","","10.1007/s10461-023-04025-z"
"24560541","Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study","Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.","Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.","Gray GE","Lancet Infect Dis","2014","2014/02/25","PMC4174314","NIHMS588579","10.1016/S1473-3099(14)70020-9"
"36179551","Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens","Huang Y, Zhang Y, Seaton KE, De Rosa S, Heptinstall J, Carpp LN, Randhawa AK, McKinnon LR, McLaren P, Viegas E, Gray GE, Churchyard G, Buchbinder SP, Edupuganti S, Bekker LG, Keefer MC, Hosseinipour MC, Goepfert PA, Cohen KW, Williamson BD, McElrath MJ, Tomaras GD, Thakar J, Kobie JJ; NIAID HIV Vaccine Trials Network (HVTN) 073/South African AIDS Vaccine Initiative (SAAVI) 102, HVTN 086/SAAVI 103, HVTN 094, HVTN 097, HVTN 098, HVTN 100, HVTN 105, HVTN 111, and HVTN 205 Protocol Leadership Teams.","EBioMedicine. 2022 Oct;84:104271. doi: 10.1016/j.ebiom.2022.104271. Epub 2022 Sep 27.","Huang Y","EBioMedicine","2022","2022/09/30","PMC9520208","","10.1016/j.ebiom.2022.104271"
"25928881","Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women","Mackelprang RD, Scoville CW, Cohen CR, Ondondo RO, Bigham AW, Celum C, Campbell MS, Essex M, Wald A, Kiarie J, Ronald A, Gray G, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.","Genes Immun. 2015 Jul-Aug;16(5):362-365. doi: 10.1038/gene.2015.13. Epub 2015 Apr 30.","Mackelprang RD","Genes Immun","2015","2015/05/01","PMC4523061","NIHMS669780","10.1038/gene.2015.13"
"32747654","Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature","Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J.","Sci Rep. 2020 Aug 3;10(1):13031. doi: 10.1038/s41598-020-69007-w.","Palli R","Sci Rep","2020","2020/08/05","PMC7398916","","10.1038/s41598-020-69007-w"
"31308962","Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa","Lazarus E, Otwombe K, Dietrich J, Andrasik MP, Morgan CA, Kublin JG, Gray GE, Isaacs AJ, Laher F.","South Afr J HIV Med. 2019 Jun 20;20(1):866. doi: 10.4102/sajhivmed.v20i1.866. eCollection 2019.","Lazarus E","South Afr J HIV Med","2019","2019/07/17","PMC6620501","","10.4102/sajhivmed.v20i1.866"
"25103167","Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial","Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept (HPTN 043) study team.","Lancet Glob Health. 2014 May;2(5):e267-77. doi: 10.1016/S2214-109X(14)70032-4. Epub 2014 Apr 8.","Coates TJ","Lancet Glob Health","2014","2014/08/09","PMC4131207","NIHMS595073","10.1016/S2214-109X(14)70032-4"
"31996422","Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection","Ditse Z, Mkhize NN, Yin M, Keefer M, Montefiori DC, Tomaras GD, Churchyard G, Mayer KH, Karuna S, Morgan C, Bekker LG, Mlisana K, Gray G, Moodie Z, Gilbert P, Moore PL, Williamson C, Morris L.","mSphere. 2020 Jan 29;5(1):e00738-19. doi: 10.1128/mSphere.00738-19.","Ditse Z","mSphere","2020","2020/01/31","PMC6992371","","10.1128/mSphere.00738-19"
"25835607","Determination of HIV Status in African Adults With Discordant HIV Rapid Tests","Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.","J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):430-8. doi: 10.1097/QAI.0000000000000610.","Fogel JM","J Acquir Immune Defic Syndr","2015","2015/04/04","PMC4483143","NIHMS673836","10.1097/QAI.0000000000000610"
"29594618","Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa","Dietrich JJ, Lazarus E, Andrasik M, Hornschuh S, Otwombe K, Morgan C, Isaacs AJ, Huang Y, Laher F, Kublin JG, Gray GE; HVTN 915 study team.","AIDS Behav. 2018 Jul;22(7):2312-2321. doi: 10.1007/s10461-018-2080-y.","Dietrich JJ","AIDS Behav","2018","2018/03/30","PMC6176864","NIHMS962370","10.1007/s10461-018-2080-y"
"34831841","Spatial and Temporal Trends of SARS-CoV-2 RNA from Wastewater Treatment Plants over 6 Weeks in Cape Town, South Africa","Street R, Mathee A, Mangwana N, Dias S, Sharma JR, Ramharack P, Louw J, Reddy T, Brocker L, Surujlal-Naicker S, Berkowitz N, Malema MS, Nkambule S, Webster C, Mahlangeni N, Gelderblom H, Mdhluli M, Gray G, Muller C, Johnson R.","Int J Environ Res Public Health. 2021 Nov 17;18(22):12085. doi: 10.3390/ijerph182212085.","Street R","Int J Environ Res Public Health","2021","2021/11/27","PMC8618134","","10.3390/ijerph182212085"
"35727802","Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial","Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, Faesen M, Khuto K, Whyte C, Bailey V, Trivella V, Peter J, Opie J, Louw V, Rowji P, Jacobson B, Groenewald P, Dorrington RE, Laubscher R, Bradshaw D, Moultrie H, Fairall L, Sanne I, Gail-Bekker L, Gray G, Goga A, Garrett N; Sisonke study team.","PLoS Med. 2022 Jun 21;19(6):e1004024. doi: 10.1371/journal.pmed.1004024. eCollection 2022 Jun.","Takuva S","PLoS Med","2022","2022/06/21","PMC9212139","","10.1371/journal.pmed.1004024"
"24963269","Frequent genital HSV-2 shedding among women during labor in Soweto, South Africa","Perti T, Nyati M, Gray G, De Bruyn G, Selke S, Magaret A, Huang ML, Velaphi S, Corey L, Wald A.","Infect Dis Obstet Gynecol. 2014;2014:258291. doi: 10.1155/2014/258291. Epub 2014 May 20.","Perti T","Infect Dis Obstet Gynecol","2014","2014/06/26","PMC4054931","","10.1155/2014/258291"
"28525965","Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment","Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.","BMC Infect Dis. 2017 May 19;17(1):355. doi: 10.1186/s12879-017-2454-1.","Patel EU","BMC Infect Dis","2017","2017/05/21","PMC5437713","","10.1186/s12879-017-2454-1"
"25090110","Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses","Hopkins KL, Laher F, Otwombe K, Churchyard G, Bekker LG, DeRosa S, Nchabeleng M, Mlisana K, Kublin J, Gray G.","PLoS One. 2014 Aug 4;9(8):e103446. doi: 10.1371/journal.pone.0103446. eCollection 2014.","Hopkins KL","PLoS One","2014","2014/08/05","PMC4121165","","10.1371/journal.pone.0103446"
"35305740","Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study","Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE; Sisonke Protocol Team; Sisonke Study Team.","Lancet. 2022 Mar 19;399(10330):1141-1153. doi: 10.1016/S0140-6736(22)00007-1.","Bekker LG","Lancet","2022","2022/03/20","PMC8930006","","10.1016/S0140-6736(22)00007-1"
"28824960","The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa","Moodley N, Gray G, Bertram M.","Clin Res HIV AIDS. 2016;3(1):1031. Epub 2016 Nov 27.","Moodley N","Clin Res HIV AIDS","2016","2017/08/22","PMC5562157","NIHMS884981",""
"26142452","Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial","Barnabas RV, Baeten JM, Lingappa JR, Thomas KK, Hughes JP, Mugo NR, Delany-Moretlwe S, Gray G, Rees H, Mujugira A, Ronald A, Stevens W, Kapiga S, Wald A, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.","J Infect Dis. 2016 Feb 15;213(4):551-5. doi: 10.1093/infdis/jiv318. Epub 2015 Jun 8.","Barnabas RV","J Infect Dis","2016","2015/07/05","PMC4721901","","10.1093/infdis/jiv318"
"31999736","Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans","Zhao LP, Fiore-Gartland A, Carpp LN, Cohen KW, Rouphael N, Fleurs L, Dintwe O, Zhao M, Moodie Z, Fong Y, Garrett N, Huang Y, Innes C, Janes HE, Lazarus E, Michael NL, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Robb ML, De Rosa SC, Corey L, Gray GE, Seaton KE, Yates NL, McElrath MJ, Frahm N, Tomaras GD, Gilbert PB.","PLoS One. 2020 Jan 30;15(1):e0226803. doi: 10.1371/journal.pone.0226803. eCollection 2020.","Zhao LP","PLoS One","2020","2020/01/31","PMC6992005","","10.1371/journal.pone.0226803"
"26850270","Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study","van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW; MTN-003 VOICE Protocol Team for Microbicide Trials Network.","J Int AIDS Soc. 2016 Feb 4;19(1):20642. doi: 10.7448/IAS.19.1.20642. eCollection 2016.","van der Straten A","J Int AIDS Soc","2016","2016/02/07","PMC4744323","","10.7448/IAS.19.1.20642"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"27828875","Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043)","Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH, Chingono AH.","J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):158-165. doi: 10.1097/QAI.0000000000001229.","Fogel JM","J Acquir Immune Defic Syndr","2017","2016/11/10","PMC5233465","NIHMS825579","10.1097/QAI.0000000000001229"
"26951820","Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02","Leitman EM, Hurst J, Mori M, Kublin J, Ndung'u T, Walker BD, Carlson J, Gray GE, Matthews PC, Frahm N, Goulder PJ.","J Infect Dis. 2016 Aug 1;214(3):379-89. doi: 10.1093/infdis/jiw093. Epub 2016 Mar 6.","Leitman EM","J Infect Dis","2016","2016/03/09","PMC4936641","","10.1093/infdis/jiw093"
"37363917","Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women","Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S.","J Int AIDS Soc. 2023 Jun;26(6):e26118. doi: 10.1002/jia2.26118.","Donnell D","J Int AIDS Soc","2023","2023/06/26","PMC10292682","","10.1002/jia2.26118"
"36250382","Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial","Asare K, Andine T, Naicker N, Dorward J, Singh N, Spooner E, Andriesen J, Osman F, Ngcapu S, Vandormael A, Mindel A, Abdool Karim SS, Bekker LG, Gray G, Corey L, Tomita A, Garrett N.","Clin Infect Dis. 2023 Mar 4;76(5):881-889. doi: 10.1093/cid/ciac824.","Asare K","Clin Infect Dis","2023","2022/10/17","PMC7614294","EMS157961","10.1093/cid/ciac824"
"37063238","Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)","Jacobson BF, Schapkaitz E, Takalani A, Rowji PF, Louw V, Opie J, Bekker LG, Garrett N, Goga A, Reddy T, Zuma NY, Sanne I, Seocharan I, Peter J, Robinson M, Collie S, Khan A, Takuva S, Gray G.","BMJ Med. 2023 Mar 23;2(1):e000302. doi: 10.1136/bmjmed-2022-000302. eCollection 2023.","Jacobson BF","BMJ Med","2023","2023/04/17","PMC10083528","","10.1136/bmjmed-2022-000302"
"26423888","Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment","Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.","BMC Infect Dis. 2015 Sep 30;15:398. doi: 10.1186/s12879-015-1130-6.","Patel EU","BMC Infect Dis","2015","2015/10/02","PMC4591065","","10.1186/s12879-015-1130-6"
"32034163","HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens","Shen X, Laher F, Moodie Z, McMillan AS, Spreng RL, Gilbert PB, Huang Y, Yates NL, Grunenberg N, Juliana McElrath M, Allen M, Pensiero M, Mehra VL, Der Meeren OV, Barnett SW, Phogat S, Gray GE, Bekker LG, Corey L, Tomaras GD.","Sci Rep. 2020 Feb 7;10(1):2093. doi: 10.1038/s41598-020-57491-z.","Shen X","Sci Rep","2020","2020/02/09","PMC7005751","","10.1038/s41598-020-57491-z"
"34742340","Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017","Miner MD, Bekker LG, Kredo T, Bhagwandin N, Corey L, Gray GE.","Trials. 2021 Nov 6;22(1):778. doi: 10.1186/s13063-021-05754-z.","Miner MD","Trials","2021","2021/11/07","PMC8572437","","10.1186/s13063-021-05754-z"
"26332672","Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials","Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB.","PLoS One. 2015 Sep 2;10(9):e0136626. doi: 10.1371/journal.pone.0136626. eCollection 2015.","Huang Y","PLoS One","2015","2015/09/03","PMC4558095","","10.1371/journal.pone.0136626"
"33160341","Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important","Laher F, Salami T, Hornschuh S, Makhale LM, Khunwane M, Andrasik MP, Gray GE, Van Tieu H, Dietrich JJ.","BMC Public Health. 2020 Nov 7;20(1):1669. doi: 10.1186/s12889-020-09785-0.","Laher F","BMC Public Health","2020","2020/11/08","PMC7648553","","10.1186/s12889-020-09785-0"
"30890385","Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa","Selinger C, Bershteyn A, Dimitrov DT, Adamson BJS, Revill P, Hallett TB, Phillips AN, Bekker LG, Rees H, Gray G.","Vaccine. 2019 Apr 10;37(16):2258-2267. doi: 10.1016/j.vaccine.2019.02.073. Epub 2019 Mar 16.","Selinger C","Vaccine","2019","2019/03/21","PMC6684280","NIHMS1043540","10.1016/j.vaccine.2019.02.073"
"33481787","Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial","Mpofu R, Otwombe K, Mlisana K, Nchabeleng M, Allen M, Kublin J, McElrath MJ, Bekker LG, Churchyard G, Gray G, Laher F.","PLoS One. 2021 Jan 22;16(1):e0241708. doi: 10.1371/journal.pone.0241708. eCollection 2021.","Mpofu R","PLoS One","2021","2021/01/22","PMC7822320","","10.1371/journal.pone.0241708"
"31095007","Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)","Lemos MP, Lazarus E, Isaacs A, Dietrich J, Morgan C, Huang Y, Grove D, Andrasik M, Laher F, Hural J, Chung E, Dragavon J, Puren A, Gulati RK, Coombs R, McElrath MJ, Gray G, Kublin JG.","J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):e39-e48. doi: 10.1097/QAI.0000000000002015.","Lemos MP","J Acquir Immune Defic Syndr","2019","2019/05/17","PMC6743720","NIHMS1522010","10.1097/QAI.0000000000002015"
"30996101","Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission","Williams-Wietzikoski CA, Campbell MS, Payant R, Lam A, Zhao H, Huang H, Wald A, Stevens W, Gray G, Farquhar C, Rees H, Celum C, Mullins JI, Lingappa JR, Frenkel LM.","J Virol. 2019 Jun 14;93(13):e01769-18. doi: 10.1128/JVI.01769-18. Print 2019 Jul 1.","Williams-Wietzikoski CA","J Virol","2019","2019/04/19","PMC6580966","","10.1128/JVI.01769-18"
"20537376","Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis","Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.","Lancet. 2010 Jun 12;375(9731):2092-8. doi: 10.1016/S0140-6736(10)60705-2. Epub 2010 May 26.","Donnell D","Lancet","2010","2010/06/12","PMC2922041","NIHMS215541","10.1016/S0140-6736(10)60705-2"
"32324753","A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa","Dietrich JJ, Hornschuh S, Khunwane M, Makhale LM, Otwombe K, Morgan C, Huang Y, Lemos M, Lazarus E, Kublin JG, Gray GE, Laher F, Andrasik M; HVTN 915 team.","PLoS One. 2020 Apr 23;15(4):e0231086. doi: 10.1371/journal.pone.0231086. eCollection 2020.","Dietrich JJ","PLoS One","2020","2020/04/24","PMC7179867","","10.1371/journal.pone.0231086"
"26368824","Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men","Moodie Z, Metch B, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, Bentley C, Gilbert PB, Robertson M, Kublin J, Corey L, Gray GE.","PLoS One. 2015 Sep 14;10(9):e0137666. doi: 10.1371/journal.pone.0137666. eCollection 2015.","Moodie Z","PLoS One","2015","2015/09/15","PMC4569275","","10.1371/journal.pone.0137666"
"27434311","Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization","Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.","PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul.","Rademeyer C","PLoS Pathog","2016","2016/07/20","PMC4951126","","10.1371/journal.ppat.1005742"
"29898870","Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial","Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, Allen M, Malahleha M, Mngadi K, Daniels B, Innes C, Bentley C, Frahm N, Morris DE, Morris L, Mkhize NN, Montefiori DC, Sarzotti-Kelsoe M, Grant S, Yu C, Mehra VL, Pensiero MN, Phogat S, DiazGranados CA, Barnett SW, Kanesa-Thasan N, Koutsoukos M, Michael NL, Robb ML, Kublin JG, Gilbert PB, Corey L, Gray GE, McElrath MJ; HVTN 100 Protocol Team.","Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.","Bekker LG","Lancet HIV","2018","2018/06/15","PMC6028742","","10.1016/S2352-3018(18)30071-7"
"25401780","Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa","Lazarus EM, Otwombe K, Adonis T, Sebastian E, Gray G, Grunenberg N, Roux S, Churchyard G, Innes C, Laher F.","PLoS One. 2014 Nov 17;9(11):e112303. doi: 10.1371/journal.pone.0112303. eCollection 2014.","Lazarus EM","PLoS One","2014","2014/11/18","PMC4234370","","10.1371/journal.pone.0112303"
"27079900","Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012","Moodley N, Gray G, Bertram M.","BMC Public Health. 2016 Apr 14;16:330. doi: 10.1186/s12889-016-2959-3.","Moodley N","BMC Public Health","2016","2016/04/16","PMC4832469","","10.1186/s12889-016-2959-3"
"25542477","Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa","Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.","J Clin Virol. 2015 Jan;62:75-9. doi: 10.1016/j.jcv.2014.11.023. Epub 2014 Nov 27.","Piwowar-Manning E","J Clin Virol","2015","2014/12/28","PMC4319362","NIHMS650377","10.1016/j.jcv.2014.11.023"
"25540368","A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component","Bricault CA, Kovacs JM, Nkolola JP, Yusim K, Giorgi EE, Shields JL, Perry J, Lavine CL, Cheung A, Ellingson-Strouss K, Rademeyer C, Gray GE, Williamson C, Stamatatos L, Seaman MS, Korber BT, Chen B, Barouch DH.","J Virol. 2015 Mar;89(5):2507-19. doi: 10.1128/JVI.03331-14. Epub 2014 Dec 24.","Bricault CA","J Virol","2015","2014/12/26","PMC4325749","","10.1128/JVI.03331-14"
"30507409","Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial","Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H.","Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24.","Delany-Moretlwe S","Lancet Infect Dis","2018","2018/12/04","","","10.1016/S1473-3099(18)30428-6"
"27583368","Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants","Churchyard G, Mlisana K, Karuna S, Williamson AL, Williamson C, Morris L, Tomaras GD, De Rosa SC, Gilbert PB, Gu N, Yu C, Mkhize NN, Hermanus T, Allen M, Pensiero M, Barnett SW, Gray G, Bekker LG, Montefiori DC, Kublin J, Corey L.","PLoS One. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753. eCollection 2016.","Churchyard G","PLoS One","2016","2016/09/02","PMC5008759","","10.1371/journal.pone.0161753"
"27098021","Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap","Gray GE, Mayer KH, Elizaga ML, Bekker LG, Allen M, Morris L, Montefiori D, De Rosa SC, Sato A, Gu N, Tomaras GD, Tucker T, Barnett SW, Mkhize NN, Shen X, Downing K, Williamson C, Pensiero M, Corey L, Williamson AL.","Clin Vaccine Immunol. 2016 Jun 6;23(6):496-506. doi: 10.1128/CVI.00717-15. Print 2016 Jun.","Gray GE","Clin Vaccine Immunol","2016","2016/04/22","PMC4895009","","10.1128/CVI.00717-15"
"26704611","Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals","Fife KH, Mugwanya K, Thomas KK, Baeten JM, Celum C, Bukusi E, de Bruyn G, Mujugira A, Vwalika B, Wald A, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.","J Infect Dis. 2016 May 15;213(10):1573-8. doi: 10.1093/infdis/jiv765. Epub 2015 Dec 23.","Fife KH","J Infect Dis","2016","2015/12/26","PMC6281349","","10.1093/infdis/jiv765"
"25389306","Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples","Kahle EM, Bolton M, Hughes JP, Donnell D, Celum C, Lingappa JR, Ronald A, Cohen CR, de Bruyn G, Fong Y, Katabira E, McElrath MJ, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.","J Infect Dis. 2015 May 1;211(9):1451-60. doi: 10.1093/infdis/jiu621. Epub 2014 Nov 10.","Kahle EM","J Infect Dis","2015","2014/11/13","PMC4447828","","10.1093/infdis/jiu621"
"20854108","Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults","Nicholson O, DiCandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV, Self S, Turner K, Sanchez J, Pitisuttithum P, Duerr A, Dubey S, Kierstead L, Casimiro D, Hammer For The Merck V/Hiv Vaccine Trials Network Study Team SM.","AIDS Res Hum Retroviruses. 2011 May;27(5):557-567. doi: 10.1089/AID.2010.0151. Epub 2010 Nov 23.","Nicholson O","AIDS Res Hum Retroviruses","2011","2010/09/22","PMC3422055","","10.1089/AID.2010.0151"
"37440227","Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials","Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, Leav B, Miller J, Hirsch I, Sadoff J, Dunkle LM, Neuzil KM, Corey L, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y; COVID-19 Prevention Network (CoVPN).","JAMA Netw Open. 2023 Jul 3;6(7):e2323349. doi: 10.1001/jamanetworkopen.2023.23349.","Theodore DA","JAMA Netw Open","2023","2023/07/13","PMC10346130","","10.1001/jamanetworkopen.2023.23349"
"32442195","Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials","Moodie Z, Walsh SR, Laher F, Maganga L, Herce ME, Naidoo S, Hosseinipour MC, Innes C, Bekker LG, Grunenberg N, Mann P, Yu C, deCamp AC, Miner MD, Yates NL, Heptinstall J, Mkhize NN, Dintwe O, Frahm N, Cohen KW, Allen M, Hutter J, Wagner R, Pantaleo G, McElrath MJ, Tomaras GD, Morris L, Montefiori DC, Andersen-Nissen E, Gray GE, Gilbert PB, Kublin JG; NIAID HVTN 100 and HVTN 111 trial teams.","PLoS Med. 2020 May 22;17(5):e1003117. doi: 10.1371/journal.pmed.1003117. eCollection 2020 May.","Moodie Z","PLoS Med","2020","2020/05/23","PMC7244095","","10.1371/journal.pmed.1003117"
"32092060","Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines","Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD.","PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.","Laher F","PLoS Med","2020","2020/02/25","PMC7039414","","10.1371/journal.pmed.1003038"
"28360202","Preventing acquisition of HIV is the only path to an AIDS-free generation","Corey L, Gray GE.","Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3798-3800. doi: 10.1073/pnas.1703236114. Epub 2017 Mar 30.","Corey L","Proc Natl Acad Sci U S A","2017","2017/04/01","PMC5393193","","10.1073/pnas.1703236114"
"23181167","A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens","Gilbert PB, Grove D, Gabriel E, Huang Y, Gray G, Hammer SM, Buchbinder SP, Kublin J, Corey L, Self SG.","Stat Commun Infect Dis. 2011 Oct;3(1):1037. doi: 10.2202/1948-4690.1037.","Gilbert PB","Stat Commun Infect Dis","2011","2012/11/28","PMC3502884","NIHMS356973","10.2202/1948-4690.1037"
